The fintech startup plans to use the newly introduced fast-track route to move its parent entity from the US to India.

The Standard Glass Lining IPO, having a price band of ₹133-140 per share, aims to raise ₹410.05 crore. The issue was ...

Both companies clearly need lots of funding to keep operating at their current scale. On Tuesday, the Wall Street Journal reported that Anthropic, known for its AI chatbot called Claude, is in ...

Maze Therapeutics has submitted its pitch for an initial public offering after disclosing a $115 million Series D, forging a ...

Sierra Space CEO Tom Vice retired on Dec. 31, the company confirmed Monday, with Chairman Fatih Ozmen stepping in as interim CEO. Sierra Space was spun off from Sierra Nevada Corporation in 2021. It's ...

Seattle-area biotech company Athira Pharma agreed to pay $4.07 million to settle allegations that it violated the False ...

Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...

The restaurant group announced Tuesday that Jose Alberto Dueñas is stepping down. Chief financial officer Paul Carbone, a ...

Just a month after announcing a $115 million series D financing to advance its lead assets, Maze Therapeutics is looking to ...

Drug developer Maze Therapeutics Inc.'s rollercoaster ride is leading to the Bay Area's first biotech IPO filing of 2025.

Demand for Big Data services is increasing. Palantir, a leader in the field, should benefit. Here are the forecasts and price ...